Pharmaceuticals(45)
-
Treatment for Drug-Resistant Non-Small Cell Lung Cancer (No. T4-1944)
Non-Small Cell Lung Cancer (NSCLC) is a very common type of cancer, and despite currently available therapies, is one of the deadliest due to the emergence of drug resistance, which results in tumor recurrence. ... Read more6025 -
Predicting Blood Metabolites (No. T4-1941)
The serum metabolome contains a plethora of biomarkers and causative agents of various diseases. They are known to be modulated by various genetic and environmental factors such as the gut microbiome, nutrition, and lifestyle. ... Read more6220 -
New Antiviral Drugs from Bacterial Natural Products (No. T4-1934)
The increasing incidence of viral infections across the globe is driving the demand for antiviral drugs. Prof. Rotem Sorek and his team identified a new family of bacterial enzymes that produce various nucleotide analogs with antiviral properties (Bernheim, Nature 2021). ... Read more12514 -
Higher Efficiency of CRISPR Gene Editing Using Chimeric Cas9 (No. T4-1930)
CRISPR-Cas9 is a powerful tool for genome editing, widely used for basic research and the development of treatments for genetic diseases. However, its efficiency is currently limited. ... Read more6024 -
Imaging Platform for IBD Drug Discovery (No. T4-1925)
Inflammatory bowel disease (IBD) is characterized by chronic inflammation of the gastrointestinal (GI) tract, resulting in its damage and gut barrier dysfunction. ... Read more5746 -
Imaging Platform for IBD Drug Discovery (No. T4-1925)
Inflammatory bowel disease (IBD) is characterized by chronic inflammation of the gastrointestinal (GI) tract, resulting in its damage and gut barrier dysfunction. ... Read more5746 -
Modulating Protein Degradation through COP9 Signalosome regulation (No. T4-1923)
A potentially therapeutic method to interfere with CSNAP activity, a key negative regulator of protein degradation. ... Read more18406 -
Protein Based Treatment for Duchene Muscular Dystrophy and Cancer (No. T4-1913)
Duchenne muscular dystrophy (DMD) is a disease that affects approximately 1 in 3,500 boys with a life expectancy of ~26 years. ... Read more6026 -
Person-specific Assessment of Probiotics Responsiveness (No. T4-1895)
Probiotics are a widely consumed dietary supplement, however, their efficacy is controversial and not all individuals benefit from their use. Therefore, a predictive tool that distinguishes between probiotic-permissive and resistant individuals is needed. ... Read more5734 -
Person-specific Assessment of Probiotics Responsiveness (No. T4-1895)
Probiotics are a widely consumed dietary supplement, however, their efficacy is controversial and not all individuals benefit from their use. Therefore, a predictive tool that distinguishes between probiotic-permissive and resistant individuals is needed. ... Read more5734
Pages
